NCT04800588 Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
| NCT ID | NCT04800588 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Neurobehavioral Systems, Inc. |
| Condition | Alzheimer Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2021-05-05 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,000 participants in total. It began in 2021-05-05 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will study performance on computerized cognitive tasks in healthy participants of different ages to gather normative data for newly developed computerized cognitive tests. These tests are designed to permit the early detection of individuals at risk of age-related cognitive decline.
Eligibility Criteria
Inclusion Criteria: * Must be able to use computer mouse and touch screen * Must speak English as a primary language * Must speak Spanish as a primary language (for Latino participants completing our Spanish translation) Exclusion Criteria: * History of psychiatric disorder * History of stroke or transient ischemic attack * History of substance abuse * History of medical or sensory disorders that are incompatible with effective testing * History of traumatic brain injury with hospitalization and extended loss of consciousness * History of epilepsy * History of depression or anxiety
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04800588 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04800588 currently recruiting?
Yes, NCT04800588 is actively recruiting participants. Contact the research team at clinical_trial_coordinator@neurobs.com for enrollment information.
Where is the NCT04800588 trial being conducted?
This trial is being conducted at Berkeley, United States.
Who is sponsoring the NCT04800588 clinical trial?
NCT04800588 is sponsored by Neurobehavioral Systems, Inc.. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.